Vitiligo trials in Italy
4 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
- Where
- Ancona, Ferrara, Milan, Rozzano
- Age
- 18 years to 99 years
- People
- 210 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07431177 · EU 2025-522301-37-00 - Phase 3Taking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Ancona, Catania, L'aquila, Milan, Naples, Perugia, Pisa, Rome, Rozzano
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
- Where
- Bologna, Brescia, Catania, Milan, Naples, Padova, Rome
- Age
- 6 years to 11 years
- People
- 250 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06804811 · EU 2024-513171-41-00 - Phase 2Not yet taking people in Italy“A phase 2 multi-center study investigating the efficacy, safety and tolerability of pioglitazone in adult participants with non-segmental vitiligo”
- Where
- Rome
- Age
- 18 years to 64 years
- People
- 60
- Run by
- I.F.O. Istituti Fisioterapici Ospitalieri
See details and how to join2025-523266-24-00